GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BIMI International Medical Inc (NAS:BIMI) » Definitions » Operating Income

BIMI International Medical (BIMI International Medical) Operating Income : $-3.89 Mil (TTM As of Sep. 2023)


View and export this data going back to 2006. Start your Free Trial

What is BIMI International Medical Operating Income?

BIMI International Medical's Operating Income for the three months ended in Sep. 2023 was $-3.15 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Sep. 2023 was $-3.89 Mil.

Warning Sign:

BIMI International Medical Inc had lost money in 75% of the time over the past 12quarters.

Operating Margin % is calculated as Operating Income divided by its Revenue. BIMI International Medical's Operating Income for the three months ended in Sep. 2023 was $-3.15 Mil. BIMI International Medical's Revenue for the three months ended in Sep. 2023 was $2.52 Mil. Therefore, BIMI International Medical's Operating Margin % for the quarter that ended in Sep. 2023 was -124.85%.

BIMI International Medical's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. BIMI International Medical's annualized ROC % for the quarter that ended in Sep. 2023 was -61.96%. BIMI International Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -135.86%.


BIMI International Medical Operating Income Historical Data

The historical data trend for BIMI International Medical's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIMI International Medical Operating Income Chart

BIMI International Medical Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.21 -0.99 -3.81 -5.78 -9.95

BIMI International Medical Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.41 -2.62 0.58 1.30 -3.15

BIMI International Medical Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BIMI International Medical  (NAS:BIMI) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

BIMI International Medical's annualized ROC % for the quarter that ended in Sep. 2023 is calculated as:

ROC % (Q: Sep. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2023 ) + Invested Capital (Q: Sep. 2023 ))/ count )
=-12.6 * ( 1 - 0% )/( (20.88 + 19.792)/ 2 )
=-12.6/20.336
=-61.96 %

where

Note: The Operating Income data used here is four times the quarterly (Sep. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

BIMI International Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2023  Q: Sep. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-12.392/( ( (4.526 + max(5.208, 0)) + (4.579 + max(3.929, 0)) )/ 2 )
=-12.392/( ( 9.734 + 8.508 )/ 2 )
=-12.392/9.121
=-135.86 %

where Working Capital is:

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6.38 + 7.183 + 9.149) - (13.846 + 0.525 + 3.133)
=5.208

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4.116 + 7.087 + 10.885) - (14.255 + 0.762 + 3.142)
=3.929

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

3. Operating Income is also linked to Operating Margin %:

BIMI International Medical's Operating Margin % for the quarter that ended in Sep. 2023 is calculated as:

Operating Margin %=Operating Income (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-3.15/2.523
=-124.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


BIMI International Medical Operating Income Related Terms

Thank you for viewing the detailed overview of BIMI International Medical's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


BIMI International Medical (BIMI International Medical) Business Description

Traded in Other Exchanges
N/A
Address
Chongqing Corporation Avenue, 9th Floor, Building 2, Yuzhong District, Chongqing, CHN, 400010
BIMI International Medical Inc is a healthcare product and provider, offering a broad range of healthcare products and related services and operates private hospitals in China. The company is engaged in four business segments, Pharmaceuticals wholesale, Medical devices wholesale, Medical services, and Pharmacy retail. It generates maximum revenue from the pharmaceuticals wholesale segment. It mainly sources its products from large state-owned pharmaceutical manufacturers and wholesalers and mid-sized or small private pharmaceutical manufacturers and wholesalers. The Company's revenues were generated in the PRC.
Executives
Ang Sammi Ean Seok director 2658 VISTA MONTE CIRCLE, CHINO HILLS CA 91709
Fnu Oudom director 7700 IRVINE CENTRE DRIVE, SUITE 800, IRVINE CA 92618
Xiaoping Wang director ROOM 4-6,NO.88-4 HUAYAN FIRST VILLAGE, SHAPINGBA DISTRICT, CHONGQING F4 400037
Baiqun Zhong officer: CFO 1-7, NO.27, HUAYAN NEW VILLAGE, JIULONGPO DISTRICT, CHONGQING F4 400039
Zhang Tingting director, officer: Chief Financial Officer 3708, FULI CENTER, NO.6 GANGXING ROOD, ZHANGSHANG DISTRICT, DALIAN, LIAONING F4 116001
Song Tiewei director 17 FLOOR, FULI CENTER NO.6,GANGXING ROOD, ZHANGSHANG DISTRICT, DALIAN, LIAONING F4 116001
Yongquan Bi 10 percent owner ROOM 3708, WANDA PLACE, 6 GANGWAN ROAD, ZHONGSHAN DISTRICT, DALIAN CITY, LIAONING PROVINCE F4 116001
Wang Lihua director, 10 percent owner, officer: Chief Financial Officer NO 4 4 12 58 BAJING ROAD, HEPING DISTRICT SHENYANG CITY, LIAONING PROVINCW F4 110003
Li Gang director, 10 percent owner, officer: President and CEO 19B3 62 WEST HINHE ROAD, SHENHE DISTRICT SHENYANG CITY, LIAONING PROVINCE F4 110000
Jiuding Yan director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021
Lesley Jin director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021
Maclean John Coleman director 112 E 4TH AVE, SUITE 206, OLYMPIA WA 98501
Zhongmin Wang director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021
Jianxin Wang director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, TIE XI QU, SHENYANG F4 110021
Mia Kuang Ching director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, TIE XI QU, SHENYANG F4 110021

BIMI International Medical (BIMI International Medical) Headlines

From GuruFocus

BIMI Announces Entering into a $5 million Stock Purchase Agreement

By GuruFocusNews GuruFocusNews 06-20-2022

BIMI to Hold Annual Shareholder Meeting on July 13, 2022

By GuruFocusNews GuruFocusNews 07-08-2022

BIMI Announces Entry into a Material Definitive Agreement

By Value_Insider Value_Insider 12-13-2022

BIMI Announces Entering into a $5 million Stock Purchase Agreement

By GuruFocusNews GuruFocusNews 06-10-2022

BIMI Announces Appointment of Mr. Fnu Oudom to Board of Directors

By GuruFocusNews GuruFocusNews 06-21-2022

BIMI to Hold Annual Shareholder Meeting on July 13, 2022

By GuruFocusNews GuruFocusNews 06-28-2022

BIMI Announces Entering into a $5 million Stock Purchase Agreement

By GuruFocusNews GuruFocusNews 07-10-2022

BIMI Announces Appointment of Mr. Fnu Oudom to Board of Directors

By GuruFocusNews GuruFocusNews 05-12-2022